# NCT04573140 (NCT04573140)

> A Study of RNA-lipid Particle (RNA-LP) Vaccines for Newly Diagnosed Pediatric High-Grade Gliomas (pHGG) and Adult Glioblastoma (GBM)

No report yet. It can be ordered.

## Registry

- Registry record: https://clinicaltrials.gov/study/NCT04573140
- Phase: PHASE1
- Status: RECRUITING
- Sponsor: University of Florida
- Conditions: Adult Glioblastoma; High Grade Glioma; WHO Grade III or IV Malignant Glioma
- Interventions: Autologous total tumor mRNA and pp65 full length (fl) lysosomal associated membrane protein (LAMP) mRNA loaded DOTAP liposome vaccine administered intravenously (RNA loaded lipid particles, RNA-LPs)
- Enrollment: 28
- Primary outcome: Manufacturing feasibility
- Primary outcome: Safety of RNA-LP vaccine
- Primary outcome: Determination of Maximum Tolerated Dose

## Indexed commentary on NCT04573140 so far

Podcasts, YouTube videos and X posts we have indexed that name the trial. This is where a report starts, not where it ends: the build searches for more, so finished reports usually cover more than this.

- 2 posts on X
- 1 post on Bluesky

## Order

Focused, $750 at most (a smaller delivered size costs its own price): https://www.erudio.com/contact?report=nct04573140